 EL shares have fallen 5.8 since Q4 FY22 results last Thursday, and remain 20 down from a year ago - a bargain in our view. Organic sales growth was just 8 in Q4 FY22 and expected to be just 7-9 in FY23, both disappointing relative to our investment case. 